Parexel is a global contract research organization (CRO) providing clinical trial management, regulatory consulting, and biopharmaceutical development services. With over 24,000 professionals and 50+ clinical sites across five continents, the company offers Phase I-IV clinical trial services, CMC regulatory strategy, and real-world evidence generation. Parexel is primarily a CRO, not a drug manufacturer.
clinical trial management, regulatory strategy and submissions, CMC consulting, real-world evidence, patient engagement
9 sites worldwide
Involvement in 28 clinical trials
No reviews available yet.
No documents available.